- 22/12/2007
- 9,044
- 5
- 98
Empresa canadense se prepara para fazer o teste.
Numinus Launches Clinical Trial Of Naturally Derived Psilocybin
Numinus Wellness (Pink: LKYSF) (TSXV: NUMI) announced the launch of a new clinical trial that will add information to an industry insider debate: is naturally produced psilocybin as good as synthetic psilocybin? Numinus’ new Phase I clinical trial, to be conducted in partnership with KGK...
finance.yahoo.com